Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SmartSteps: PrEP Adherence Intervention for MSM With Substance Use Disorder
NCT05378399Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2022
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Brigham and Women's Hospital. Primary endpoints: PrEP Adherence Patterns at 2 months and Correlation of PrEP Adherence with Digital Phenotyping Patterns at 2 months. Started Dec 2022; status: completed.
Beyond the preview
Go deeper on NCT05378399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378399.